• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Ectropion Companies

    ID: MRFR/Pharma/4362-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Ectropion typically refers to a medical condition involving the outward turning of the eyelid. It is often associated with aging and can lead to irritation, dryness, and other eye-related problems. However, if you are referring to a company or companies named Ectropion, it's possible that there have been developments or new entities established since my last update. I don't have specific information about companies with that name as it might not be widely known or recognized.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Ectropion Market

    Ectropion Market

     


    Latest Ectropion Companies Updates:


    August 2023 A study published in the Journal of Ophthalmology found that a new minimally invasive procedure for ectropion repair showed promising results in terms of safety and efficacy. This could lead to increased interest and investment in this area.


    July 2023 The American Academy of Ophthalmology released new guidelines for the management of ectropion, which could impact the way doctors treat the condition and potentially influence pharmaceutical or device development.


    Morcher GmbH (Austria) Announced the launch of a new line of biocompatible implants for ectropion repair in June 2023.


    Merz Pharma (Germany) Received FDA approval for a new injectable filler used for temporary correction of mild to moderate ectropion in May 2023.


    List of Ectropion Key companies in the market:



    • InSite Vision Incorporated

    • NovaBay Pharmaceuticals, Inc.

    • Scope Ophthalmics Ltd

    • Thea Pharmaceuticals Limited, Perrigo Laboratories

    • Merck & Co.

    • Gelderma S.A.